LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi, a leading provider of injectable medications, announced today it has launched Rocuronium Bromide Injection with advanced RFID-enabled labels in the ...
LAKE ZURICH, Ill.--(BUSINESS WIRE)--#CommittedToLife--Fresenius Kabi, an Operating Company of Fresenius, and a leading provider of essential medicines and medical technologies, announced today it has ...
The Food and Drug Administration (FDA) is notifying healthcare professionals regarding the temporary absence of the “paralyzing agent” warning statement on vial caps of vecuronium bromide for ...
Preterm infants requiring nonemergent intubation were randomized to receive atropine and fentanyl with or without rocuronium. Outcomes, patient characteristics and intubator's experience were noted.
Fresenius Kabi, a provider of injectable medications, has announced the U.S. launch of its Rocuronium Bromide Injection, a product offered with RFID-enabled labels. Rocuronium Bromide Injection is ...
SCHAUMBURG, Ill., Aug. 2 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, today announced two FDA approvals -- sumatriptan succinate injection and ...
Fresenius Kabi, an operating company of Fresenius, and a leading provider of essential medicines and medical technologies, announced it has launched rocuronium bromide injection room temperature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results